Norway· NO-ID_2BC8E376-0912-43B1-82B4-EEE1035F2077

Litican

A alizapride product containing alizapride, registered in Norway by sanofi-aventis (2). The same ATC class is registered in 3 of our 19 countries.

ATC A03FA05

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedLiticanATCA03FA05REGISTER NO.NO-ID_2BC8E376-0912-4…PACKS LISTED3CHECKEDSeptember 25, 2026

Where it is registered

Alizapride is registered in 3 of 19 countries.

Countries holding a registration under ATC A03FA05 (alizapride), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 3 of them publish a price we can compare per daily dose

Alizapride · ATC A03FA05

3 / 19 countries

  • Belgiumprice
  • Italyprice
  • Norwayprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Alizapride
Manufacturer
sanofi-aventis (2)
Country
Norway (NO)
ATC code
A03FA05
ATC class
Alizapride
Defined daily dose
0.15 g, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

  • no_merkevare_id
    ID_2BC8E376-0912-43B1-82B4-EEE1035F2077
  • no_varenummer
    266801
    20 x 1
  • gtin
    3582910086901

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Alizapride in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All alizapride products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Belgium · Litican
  • France · Plitican
  • Italy · Limican
  • Luxembourg · Litican

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dbd4656c-4565-4d80-b9d9-644e86aa72a9
GET /v1/drugs/dbd4656c-4565-4d80-b9d9-644e86aa72a9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett",
  "source": "fest",
  "status": "A",
  "atc_name": "Alisaprid",
  "merkevare_id": "ID_2BC8E376-0912-43B1-82B4-EEE1035F2077",
  "name_form_strength": "Litican tab 50 mg",
  "prescription_group": "C"
}

See everything about alizapride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.